Southwest Research Institute

swri.org

Southwest Research Institute is an independent, nonprofit, applied research and development organization. The staff numbers nearly 2,600 professionals specializing in the creation and transfer of technology in engineering and the physical sciences. Total revenue for fiscal year 2017 was more than $528 million. SwRI headquarters occupy more than 1,200 acres in San Antonio, Texas, and provide more than 2 million square feet of laboratories, test facilities, workshops, and offices.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

INTRON CONFIRMS EFFICACY OF CDL200 AGAINST CDI CLINICAL ISOLATES

iNtRON Biotechnology | July 12, 2022

news image

iNtRON Biotechnology announced that CDL200, a novel biological drug candidate under the development of the world's first enteric colon-targeted capsule formulation for the treatment of intractable and recurrent CDI confirmed the strong efficacy against clinical isolates from CDI patients. A company official explained that the antibacterial activity of CDL200 was evaluated for 20 clinical isolates from patients in Europe and Korea, and rapid lysis effect within few minutes afte...

Read More

Medical

ACROBAT GENOMICS, NANOSTRING, AND ILLUMINA ACCELERATOR COLLABORATE WITH STANFORD MEDICINE TO DISCOVER NEW DRUG TARGETS

Businesswire | June 09, 2023

news image

Acrobat Genomics, NanoString Technologies, Inc. and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis. NanoString’s GeoMx DSP is a powerful spatial biology platform that ...

Read More

APTORUM GROUP JOINS THE BEAM ALLIANCE TO COMBAT ANTIMICROBIAL RESISTANCE

Business Wire | September 08, 2020

news image

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation therapeutics targeting antimicrobial resistance, today announced it joined the Biotech companies in Europe combating Antimicrobial Resistance Alliance based in Europe (the “BEAM Alliance”) as full member. The BEAM Alliance is a network of approximately 70 small and medium-sized European companies...

Read More

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

news image

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More
news image

Industrial Impact

INTRON CONFIRMS EFFICACY OF CDL200 AGAINST CDI CLINICAL ISOLATES

iNtRON Biotechnology | July 12, 2022

iNtRON Biotechnology announced that CDL200, a novel biological drug candidate under the development of the world's first enteric colon-targeted capsule formulation for the treatment of intractable and recurrent CDI confirmed the strong efficacy against clinical isolates from CDI patients. A company official explained that the antibacterial activity of CDL200 was evaluated for 20 clinical isolates from patients in Europe and Korea, and rapid lysis effect within few minutes afte...

Read More
news image

Medical

ACROBAT GENOMICS, NANOSTRING, AND ILLUMINA ACCELERATOR COLLABORATE WITH STANFORD MEDICINE TO DISCOVER NEW DRUG TARGETS

Businesswire | June 09, 2023

Acrobat Genomics, NanoString Technologies, Inc. and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis. NanoString’s GeoMx DSP is a powerful spatial biology platform that ...

Read More
news image

APTORUM GROUP JOINS THE BEAM ALLIANCE TO COMBAT ANTIMICROBIAL RESISTANCE

Business Wire | September 08, 2020

Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation therapeutics targeting antimicrobial resistance, today announced it joined the Biotech companies in Europe combating Antimicrobial Resistance Alliance based in Europe (the “BEAM Alliance”) as full member. The BEAM Alliance is a network of approximately 70 small and medium-sized European companies...

Read More
news image

Medical

ZENFOLD LEVERAGES GINKGO ENZYME SERVICES TO ENABLE VETERINARY ACTIVE INGREDIENT DEVELOPMENT WITH SUSTAINABLE BIOLOGY

PR Newswire | October 17, 2023

Ginkgo Bioworks which is building the leading platform for cell programming and biosecurity, and Zenfold Sustainable Technologies, a company focused on developing and manufacturing specialty ingredients using sustainable technologies and precision fermentation, today announced a collaboration to leverage Ginkgo Enzyme Services in its effort to discover an enzyme critical to the manufac...

Read More